EUVIMEDEUVIMED entdecken
Crossref

Bone marrow mesenchymal stem cell-derived exosomes ameliorate intervertebral disc degeneration by regulating HMGB1 acetylation via SIRT6

Hongshen Wang, Yong Wen, Laoqi Mai, Xinyi Li, Yongpeng Lin, Zhifeng Xiao, Yongjin Li, Yuyi Zhang, Bolai Chen

Biochemical and Biophysical Research Communications · 2026-05 · 814 · 153648

DOI: 10.1016/j.bbrc.2026.153648 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026-05. Verfasst von Hongshen Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510120, China; Guangdong Provincial Hospital of Chi…. Hauptthemen laut MEDLINE: HMGB1 Protein, Sirtuins, Exosomes, Mesenchymal Stem Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: Department of Science and Technology of Guangdong Province, Department of Education of Guangdong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Intervertebral disc degeneration (IVDD) is a leading cause of low back and leg pain and is primarily driven by inflammation-induced apoptosis of nucleus pulposus (NP) cells. Bone marrow mesenchymal stem cell-derived exosomes (BMSC-exos) have shown strong therapeutic potential for degenerative diseases. Sirtuin 6 (SIRT6), a key regulator of aging and inflammation, has been closely associated with IVDD progression. Therefore, we hypothesized that BMSC-exos might alleviate IVDD by promoting SIRT6-mediated deacetylation of high mobility group box 1 (HMGB1), thereby suppressing inflammation. METHODS: In the present study, BMSC-exos were isolated from BMSCs and characterized using transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and Western blot analysis. The mechanisms by which BMSC-exos regulate the SIRT6/HMGB1/Toll-like receptor 4 (TLR4)/nuclear factor kappa-B (NF-κB) signaling pathway were investigated using Cell Counting Kit-8 (CCK-8) assay, reverse transcription-quantitative polymerase chain reaction, western blotting, ELISA, and immunofluorescence analysis. The therapeutic efficacy of BMSC-exos in vivo was evaluated by hematoxylin and eosin (H&E) staining, ELISA, immunofluorescence staining, and TUNEL assays. RESULTS: BMSC-exos upregulated SIRT6 expression, promoted HMGB1 deacetylation, and prevented the nuclear-to-cytoplasmic translocation of HMGB1, thereby inhibiting activation of the HMGB1/TLR4/NF-κB signaling pathway, alleviating inflammation in IVDD, and protecting NP cells in vitro. Furthermore, BMSC-exos suppressed inflammatory responses, reduced NP cell apoptosis, and attenuated IVDD progression in vivo. CONCLUSIONS: To our knowledge, this study provides the first evidence that BMSC-exos inhibit inflammation by regulating the SIRT6/HMGB1/TLR4/NF-κB pathway, thereby attenuating IVDD progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HMGB1 ProteinSirtuinsExosomesMesenchymal Stem CellsIntervertebral Disc DegenerationAnimalsRats, Sprague-DawleyAcetylationToll-Like Receptor 4MaleSignal TransductionRatsNF-kappa BCells, CulturedApoptosisHumans

Stichwörter der Autor:innen

Bone mesenchymal stem cellsExosomesHMGB1InflammationIntervertebral disc degenerationSIRT6

Substanzen

HMGB1 ProteinSirtuinssirtuin 6, ratToll-Like Receptor 4NF-kappa BHbp1 protein, rat

Autor:innen und Institutionen

  • The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510120, China; Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510120, China; The Second Clinica…
  • The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510120, China; Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510120, China.
  • The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510120, China.
  • Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510120, China.
  • The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510120, China; Guangdong Pharmaceutical University, Guangzhou, Guangdong, 510006, China.
  • The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510120, China; Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510120, China. Electronic address…

Förderung

  • Department of Science and Technology of Guangdong Province
  • Department of Education of Guangdong Province
  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Guangzhou Municipal Science and Technology Project
  • Guangdong Hospital of Traditional Chinese Medicine

Zitieren

APA

Wang, H., Wen, Y., Mai, L., Li, X., Lin, Y., Xiao, Z., Li, Y., Zhang, Y., & Chen, B. (2026). Bone marrow mesenchymal stem cell-derived exosomes ameliorate intervertebral disc degeneration by regulating HMGB1 acetylation via SIRT6. Biochemical and Biophysical Research Communications, 814, 153648. https://doi.org/10.1016/j.bbrc.2026.153648

Vancouver

Wang H, Wen Y, Mai L, Li X, Lin Y, Xiao Z, et al. Bone marrow mesenchymal stem cell-derived exosomes ameliorate intervertebral disc degeneration by regulating HMGB1 acetylation via SIRT6. Biochemical and Biophysical Research Communications. 2026;814:153648. doi:10.1016/j.bbrc.2026.153648

BibTeX
@article{Wang2026,
  author = {Wang, Hongshen and Wen, Yong and Mai, Laoqi and Li, Xinyi and Lin, Yongpeng and Xiao, Zhifeng and Li, Yongjin and Zhang, Yuyi and Chen, Bolai},
  title = {Bone marrow mesenchymal stem cell-derived exosomes ameliorate intervertebral disc degeneration by regulating HMGB1 acetylation via SIRT6},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2026},
  volume = {814},
  pages = {153648},
  doi = {10.1016/j.bbrc.2026.153648}
}
Kostenlos starten →